Screener
Myriad Genetics MYGN Free cash flow
Discontinued — last reported Q2 '23
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Myriad Genetics’s reported figures.
The source filing: Myriad Genetics’s 10-Q, filed August 7, 2024. Open the filing →
- Filed
- Aug 7, 2024
- Fiscal quarter
- Q2 FY2024
- Calendar quarter
- Q2 2024
- Accession
- 0000899923-24-000041
FAQ
- What is Myriad Genetics's free cash flow?
- Myriad Genetics (MYGN) reported free cash flow of -$19.7M in Q2 2023.
- How has Myriad Genetics's free cash flow changed year-over-year?
- Myriad Genetics's free cash flow increased by 65.1% year-over-year, from -$56.4M to -$19.7M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Myriad Genetics's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude